A citation-based method for searching scientific literature

Lia Bally, David Herzig, Yue Ruan, Malgorzata E Wilinska, Mariam Semmo, Andreas Vogt, Maria M Wertli, Bruno Vogt, Christoph Stettler, Roman Hovorka. Diabetes Obes Metab 2019
Times Cited: 8







List of co-cited articles
28 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Faster Compared With Standard Insulin Aspart During Day-and-Night Fully Closed-Loop Insulin Therapy in Type 1 Diabetes: A Double-Blind Randomized Crossover Trial.
Klemen Dovc, Claudia Piona, Gül Yeşiltepe Mutlu, Natasa Bratina, Barbara Jenko Bizjan, Dusanka Lepej, Revital Nimri, Eran Atlas, Ido Muller, Olga Kordonouri,[...]. Diabetes Care 2020
30
62

Elucidating the Mechanism of Absorption of Fast-Acting Insulin Aspart: The Role of Niacinamide.
Jonas Kildegaard, Stephen T Buckley, Rasmus H Nielsen, Gro K Povlsen, Torben Seested, Ulla Ribel, Helle B Olsen, Svend Ludvigsen, Claus B Jeppesen, Hanne H F Refsgaard,[...]. Pharm Res 2019
34
62



Investigation of Pump Compatibility of Fast-Acting Insulin Aspart in Subjects With Type 1 Diabetes.
Eric Zijlstra, Marek Demissie, Tina Graungaard, Tim Heise, Leszek Nosek, Bruce Bode. J Diabetes Sci Technol 2018
26
37

BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized euglycemic clamp study.
Tim Heise, Grégory Meiffren, Bertrand Alluis, Cyril Seroussi, Aymeric Ranson, Jorge Arrubla, José Correia, Martin Gaudier, Olivier Soula, Rémi Soula,[...]. Diabetes Obes Metab 2019
21
37

A randomized, multicentre trial evaluating the efficacy and safety of fast-acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5).
David C Klonoff, Mark L Evans, Wendy Lane, Hans-Peter Kempe, Eric Renard, J Hans DeVries, Tina Graungaard, Agon Hyseni, Theis Gondolf, Tadej Battelino. Diabetes Obes Metab 2019
32
37


Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 Trial.
Bruce W Bode, Violeta Iotova, Margarita Kovarenko, Lori M Laffel, Paturi V Rao, Srikanth Deenadayalan, Magnus Ekelund, Steffen Falgreen Larsen, Thomas Danne. Diabetes Care 2019
16
37

Pharmacokinetics of Faster and Standard Insulin Aspart During Fully Closed-Loop Insulin Delivery in Type 2 Diabetes.
David Herzig, Joachim Dehais, Jean-Christophe Prost, Christos T Nakas, Christoph Stettler, Lia Bally, Roman Hovorka. Diabetes Technol Ther 2020
3
100

Closed-Loop Insulin Delivery for Glycemic Control in Noncritical Care.
Lia Bally, Hood Thabit, Sara Hartnell, Eveline Andereggen, Yue Ruan, Malgorzata E Wilinska, Mark L Evans, Maria M Wertli, Anthony P Coll, Christoph Stettler,[...]. N Engl J Med 2018
78
25

Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors.
Jessica R Castle, Joseph El Youssef, Leah M Wilson, Ravi Reddy, Navid Resalat, Deborah Branigan, Katrina Ramsey, Joseph Leitschuh, Uma Rajhbeharrysingh, Brian Senf,[...]. Diabetes Care 2018
70
25

Faster Aspart Versus Insulin Aspart as Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes: The onset 2 Trial.
Keith Bowering, Christopher Case, John Harvey, Michael Reeves, Michael Sampson, Robert Strzinek, Ditte-Marie Bretler, Rikke Beck Bang, Bruce W Bode. Diabetes Care 2017
51
25

Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus.
Birgit Fullerton, Andrea Siebenhofer, Klaus Jeitler, Karl Horvath, Thomas Semlitsch, Andrea Berghold, Johannes Plank, Thomas R Pieber, Ferdinand M Gerlach. Cochrane Database Syst Rev 2016
33
25

Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.
C Lalli, M Ciofetta, P Del Sindaco, E Torlone, S Pampanelli, P Compagnucci, M G Cartechini, L Bartocci, P Brunetti, G B Bolli. Diabetes Care 1999
159
25

The challenges of achieving postprandial glucose control using closed-loop systems in patients with type 1 diabetes.
Véronique Gingras, Nadine Taleb, Amélie Roy-Fleming, Laurent Legault, Rémi Rabasa-Lhoret. Diabetes Obes Metab 2018
42
25

Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52-week, randomized, treat-to-target, phase III trial.
Chantal Mathieu, Bruce W Bode, Edward Franek, Athena Philis-Tsimikas, Ludger Rose, Tina Graungaard, Anne Birk Østerskov, David Russell-Jones. Diabetes Obes Metab 2018
47
25


Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.
A Siebenhofer, J Plank, A Berghold, K Jeitler, K Horvath, M Narath, R Gfrerer, T R Pieber. Cochrane Database Syst Rev 2006
123
25

Insulin analogues and their potential in the management of diabetes mellitus.
G B Bolli, R D Di Marchi, G D Park, S Pramming, V A Koivisto. Diabetologia 1999
255
25

Use of fast-acting insulin aspart in insulin pump therapy in clinical practice.
Mark Evans, Antonio Ceriello, Thomas Danne, Christophe De Block, J Hans DeVries, Marcus Lind, Chantal Mathieu, Kirsten Nørgaard, Eric Renard, Emma G Wilmot. Diabetes Obes Metab 2019
19
25

Fast-acting insulin aspart versus insulin aspart in the setting of insulin degludec-treated type 1 diabetes: Efficacy and safety from a randomized double-blind trial.
John B Buse, Anders L Carlson, Mitsuhisa Komatsu, Ofri Mosenzon, Ludger Rose, Bo Liang, Kristine Buchholtz, Hiroshi Horio, Takashi Kadowaki. Diabetes Obes Metab 2018
27
25

Fast-acting insulin aspart in people with type 2 diabetes: Earlier onset and greater initial exposure and glucose-lowering effect compared with insulin aspart.
Thomas R Pieber, Eva Svehlikova, Martina Brunner, Inge B Halberg, Karen Margrete Due Thomsen, Hanne Haahr. Diabetes Obes Metab 2019
9
25

Insulin pharmacokinetics.
C Binder, T Lauritzen, O Faber, S Pramming. Diabetes Care 1984
350
25

Top-down mass spectrometric immunoassay for human insulin and its therapeutic analogs.
Dobrin Nedelkov, Eric E Niederkofler, Paul E Oran, Scott Peterman, Randall W Nelson. J Proteomics 2018
13
25

An automated, high-throughput method for targeted quantification of intact insulin and its therapeutic analogs in human serum or plasma coupling mass spectrometric immunoassay with high resolution and accurate mass detection (MSIA-HR/AM).
Scott Peterman, Eric E Niederkofler, David A Phillips, Bryan Krastins, Urban A Kiernan, Kemmons A Tubbs, Dobrin Nedelkov, Amol Prakash, Maryann S Vogelsang, Tara Schoeder,[...]. Proteomics 2014
45
25

Greater early postprandial suppression of endogenous glucose production and higher initial glucose disappearance is achieved with fast-acting insulin aspart compared with insulin aspart.
Ananda Basu, Thomas R Pieber, Ann K Hansen, Stefanie Sach-Friedl, Lars Erichsen, Rita Basu, Hanne Haahr. Diabetes Obes Metab 2018
19
25

A Novel Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Randomized Controlled Crossover Trial.
Ahmad Haidar, Michael A Tsoukas, Sarah Bernier-Twardy, Jean-Francois Yale, Joanna Rutkowski, Anne Bossy, Evelyne Pytka, Anas El Fathi, Natalia Strauss, Laurent Legault. Diabetes Care 2020
42
25

The importance of prandial insulin bolus timing with hybrid closed-loop systems.
C K Boughton, S Hartnell, J M Allen, R Hovorka. Diabet Med 2019
4
25



Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia.
J C Pickup, H Keen, J A Parsons, K G Alberti. Br Med J 1978
460
12

Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis.
Eleni Bekiari, Konstantinos Kitsios, Hood Thabit, Martin Tauschmann, Eleni Athanasiadou, Thomas Karagiannis, Anna-Bettina Haidich, Roman Hovorka, Apostolos Tsapas. BMJ 2018
164
12

Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.
Jan Bolinder, Ramiro Antuna, Petronella Geelhoed-Duijvestijn, Jens Kröger, Raimund Weitgasser. Lancet 2016
406
12

Meta-analysis of artificial pancreas trials: methodological considerations - Authors' reply.
Alanna Weisman, Caroline K Kramer, Bruce A Perkins. Lancet Diabetes Endocrinol 2017
1
100

Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes.
Gregory P Forlenza, Orit Pinhas-Hamiel, David R Liljenquist, Dorothy I Shulman, Timothy S Bailey, Bruce W Bode, Michael A Wood, Bruce A Buckingham, Kevin B Kaiserman, John Shin,[...]. Diabetes Technol Ther 2019
73
12

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.
Sue A Brown, Boris P Kovatchev, Dan Raghinaru, John W Lum, Bruce A Buckingham, Yogish C Kudva, Lori M Laffel, Carol J Levy, Jordan E Pinsker, R Paul Wadwa,[...]. N Engl J Med 2019
223
12

Closed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes.
Zoe A Stewart, Malgorzata E Wilinska, Sara Hartnell, Rosemary C Temple, Gerry Rayman, Katharine P Stanley, David Simmons, Graham R Law, Eleanor M Scott, Roman Hovorka,[...]. N Engl J Med 2016
99
12

Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
Roy W Beck, Tonya Riddlesworth, Katrina Ruedy, Andrew Ahmann, Richard Bergenstal, Stacie Haller, Craig Kollman, Davida Kruger, Janet B McGill, William Polonsky,[...]. JAMA 2017
451
12

Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial.
Roy W Beck, Tonya D Riddlesworth, Katrina Ruedy, Andrew Ahmann, Stacie Haller, Davida Kruger, Janet B McGill, William Polonsky, David Price, Stephen Aronoff,[...]. Ann Intern Med 2017
191
12

Efficacy of single-hormone and dual-hormone artificial pancreas during continuous and interval exercise in adult patients with type 1 diabetes: randomised controlled crossover trial.
Nadine Taleb, Ali Emami, Corinne Suppere, Virginie Messier, Laurent Legault, Martin Ladouceur, Jean-Louis Chiasson, Ahmad Haidar, Rémi Rabasa-Lhoret. Diabetologia 2016
58
12

Glycaemic control in individuals with type 1 diabetes using an open source artificial pancreas system (OpenAPS).
Andreas Melmer, Thomas Züger, Dana M Lewis, Scott Leibrand, Christoph Stettler, Markus Laimer. Diabetes Obes Metab 2019
29
12

IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.
N H Cho, J E Shaw, S Karuranga, Y Huang, J D da Rocha Fernandes, A W Ohlrogge, B Malanda. Diabetes Res Clin Pract 2018
12

Closed-Loop Insulin for Glycemic Control in Noncritical Care.
Lia Bally, Hood Thabit, Roman Hovorka. N Engl J Med 2018
4
25

Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
Stuart A Weinzimer, Garry M Steil, Karena L Swan, Jim Dziura, Natalie Kurtz, William V Tamborlane. Diabetes Care 2008
324
12

Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes.
Richard M Bergenstal, Satish Garg, Stuart A Weinzimer, Bruce A Buckingham, Bruce W Bode, William V Tamborlane, Francine R Kaufman. JAMA 2016
313
12

REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes.
Grazia Aleppo, Katrina J Ruedy, Tonya D Riddlesworth, Davida F Kruger, Anne L Peters, Irl Hirsch, Richard M Bergenstal, Elena Toschi, Andrew J Ahmann, Viral N Shah,[...]. Diabetes Care 2017
131
12

A comparison of preprandial insulin glulisine versus insulin lispro in people with Type 2 diabetes over a 12-h period.
Stephen Luzio, Rajesh Peter, Gareth J Dunseath, Laila Mustafa, David R Owens. Diabetes Res Clin Pract 2008
26
12

Pursuit of a perfect insulin.
Alexander N Zaykov, John P Mayer, Richard D DiMarchi. Nat Rev Drug Discov 2016
119
12

Coverage of Prandial Insulin Requirements: An Elusive Goal.
Lutz Heinemann, Douglas Muchmore. Diabetes Technol Ther 2017
4
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.